These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31198296)

  • 1. Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.
    Singh S; Nair AG; Alam MS; Mukherjee B
    Oman J Ophthalmol; 2019; 12(2):104-107. PubMed ID: 31198296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction.
    Ziahosseini K; Al-Abbadi Z; Malhotra R
    Eye (Lond); 2015 May; 29(5):656-61. PubMed ID: 25744443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
    Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
    J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.
    Kaynak P; Karabulut GO; Ozturker C; Fazil K; Arat YO; Perente I; Akar S; Yilmaz OF; Demirok A
    Eye (Lond); 2016 Aug; 30(8):1056-62. PubMed ID: 27197871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacrimal gland botulinum toxin injection for epiphora management.
    Jeffers J; Lucarelli K; Akella S; Setabutr P; Wojno TH; Aakalu V
    Orbit; 2022 Apr; 41(2):150-161. PubMed ID: 34396904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Effectiveness of Lacrimal Gland Botulinum Toxin Using the TEARS Score.
    Hunt SV; Schulz CB; Malhotra R
    Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):192-197. PubMed ID: 38427833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on use of botulinum toxin for intractable lacrimal drainage disorders.
    Singh S; Ali MJ; Paulsen F
    Int Ophthalmol; 2018 Oct; 38(5):2233-2238. PubMed ID: 28766277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
    Girard B; Piaton JM; Keller P; Nguyen TH
    J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma.
    Vinay Kumar S; Kumar V; Mishra S; Sati A
    Med J Armed Forces India; 2023; 79(5):584-589. PubMed ID: 37719907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for functional epiphora with botulinum toxin-A versus lateral tarsal strip in a randomized trial.
    Maroto Rodríguez B; Stoica BTL; Toledano Fernández N; Genol Saavedra I
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Oct; 97(10):549-557. PubMed ID: 35879178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of Botulinum Toxin A in the Lacrimal Gland for Treatment of Epiphora in Crocodile Tears Syndrome - A Case Report.
    Lima-Fontes M; Leuzinger-Dias M; Falcão-Reis F; Sousa C
    Int Med Case Rep J; 2022; 15():537-542. PubMed ID: 36171912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.
    Ahn C; Kang S; Sa HS
    Eye (Lond); 2019 Jun; 33(6):995-999. PubMed ID: 30765885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.
    Wojno TH
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):119-21. PubMed ID: 21224749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Versus Anatomical Nasolacrimal Obstruction: Are There Differences in Epiphora Severity, Symptoms, or Effects on Quality of Life?
    Shapira Y; Macri C; Selva D
    Ophthalmic Plast Reconstr Surg; 2022 Nov-Dec 01; 38(6):567-570. PubMed ID: 35502798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of External Dacryocystorhinostomy and Monocanalicular Intubation in Patients with Total Obstruction of One Canalicus.
    Buttanri IB; Buttanri B; Serin D
    Korean J Ophthalmol; 2019 Apr; 33(2):138-141. PubMed ID: 30977323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.
    Lee AG; Lee SH; Jang M; Lee SJ; Shin HJ
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33494380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children.
    Eustis HS; Babiuch A
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.